Market Overview

UPDATE: JP Morgan Upgrades Aetna to Overweight on Revised Numbers Post Deal Closure

Share:
Related AET
Benzinga's Top Upgrades
UBS Has Had Enough: Centene Upgraded To Buy On 'Underappreciated Opportunities'
Aetna (AET): Can its Earnings Surprise Estimates in Q2? - Analyst Blog (Zacks)

JP Morgan raised its rating on Aetna (NYSE: AET) from Neutral to Overweight and increased its price target from $46 to $52.

JP Morgan said, "We are upgrading Aetna to Overweight from Neutral and raising our price target from $46 to $52 on the expectation of upwardly revised numbers post CVH deal closing, AET's below-average reform exposure and most importantly an increasing recognition of the company's ACO positioning. From a catalyst perspective, at next Wednesday's investor day we expect initial 2013 EPS guidance in the $5.40 range (JPM $5.40, consensus $5.51), within the range of investor expectations."

Aetna closed at $43.43 on Thursday.

Latest Ratings for AET

DateFirmActionFromTo
Jul 2015Bank of AmericaUpgradesNeutralBuy
Jul 2015FBR CapitalDowngradesOutperformMarket Perform
Jul 2015BarclaysMaintainsOverweight

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (AET)

Get Benzinga's Newsletters